Portfolio Companies 2026 for Redmile Group: investors, rounds, and co-investor patterns from StartupFundraising.com research, updated for 2026.
Redmile Group accounts for 41 tracked companies with verified cap-table data, 41 of which disclose round sizes totalling $12B. The median disclosed raise is $150M, and the largest is Kymera Therapeutics at $3B, ahead of ElevateBio ($1.3B) and Saluda Medical ($664M).
The names that recur most often on these portfolio cap tables are Redmile Group (42 companies), Invus (7 companies), Bain Capital Life Sciences (6 companies), Janus Henderson Investors (6 companies), RA Capital Management (6 companies), Cormorant Asset Management (6 companies). By latest disclosed round, the market skews Series B (9), Series A (8), Series C (7), Series D (7).
Companies tracked: 41
Disclosed funding total: $12B across 41 companies
Median disclosed raise: $150M
Largest raise: Kymera Therapeutics — $3B
Stage mix: Series B 9 · Series A 8 · Series C 7 · Series D 7
